Jeroen J Janssen

Jeroen J W M Janssen

UNVERIFIED PROFILE

Are you Jeroen J W M Janssen?   Register this Author

Register author
Jeroen J Janssen

Jeroen J W M Janssen

Publications by authors named "Jeroen J W M Janssen"

44Publications

968Reads

46Profile Views

1PubMed Central Citations

Survival of early posthematopoietic stem cell transplantation relapse of myeloid malignancies.

Eur J Haematol 2019 Nov 14;103(5):491-499. Epub 2019 Aug 14.

Department of Hematology, Amsterdam University Medical Centers, Location AMC, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13315DOI Listing
November 2019

Feasibility of and patients' perspective on nilotinib dried blood spot self-sampling.

Eur J Clin Pharmacol 2019 Jun 7;75(6):825-829. Epub 2019 Feb 7.

Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-019-02640-1DOI Listing
June 2019

Satisfaction with information on nilotinib treatment in chronic myeloid leukemia patients.

Acta Oncol 2019 Jun 25;58(6):891-896. Epub 2019 Mar 25.

a Department of Clinical Pharmacology and Pharmacy , Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam , Amsterdam , Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2019.1585944DOI Listing
June 2019

Validation of the EUTOS long-term survival score in a recent independent cohort of "real world" CML patients.

Leukemia 2018 10 19;32(10):2299-2303. Epub 2018 Apr 19.

Department of Internal Medicine/Hematology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0136-7DOI Listing
October 2018

Needs for information and reasons for (non)adherence in chronic myeloid leukaemia: Be aware of social activities disturbing daily routines.

Eur J Haematol 2018 Jul 30. Epub 2018 Jul 30.

Amsterdam UMC, Vrije Universiteit Amsterdam, Clinical Pharmacology and Pharmacy, Cancer Center Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13155DOI Listing
July 2018

Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe.

Eur J Haematol 2018 Apr 7;100(4):367-371. Epub 2018 Feb 7.

Department of Hematology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ejh.13023
Publisher Site
http://dx.doi.org/10.1111/ejh.13023DOI Listing
April 2018

Patient satisfaction with information on oral anticancer agent use.

Cancer Med 2018 01 23;7(1):219-228. Epub 2017 Nov 23.

Cancer Center Amsterdam, Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1239DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773956PMC
January 2018

Ponatinib in chronic myeloid leukemia (CML): Consensus on patient treatment and management from a European expert panel.

Crit Rev Oncol Hematol 2017 Dec 8;120:52-59. Epub 2017 Oct 8.

Department of Hematology and Oncology "L. and A. Seràgnoli," St Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10408428173006
Publisher Site
http://dx.doi.org/10.1016/j.critrevonc.2017.10.002DOI Listing
December 2017

Dried blood spot sampling of nilotinib in patients with chronic myeloid leukaemia: a comparison with venous blood sampling.

J Pharm Pharmacol 2017 Oct 23;69(10):1265-1274. Epub 2017 Jun 23.

Cancer Center Amsterdam, Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jphp.12757
Publisher Site
http://dx.doi.org/10.1111/jphp.12757DOI Listing
October 2017

Influence of WHO versus ELN advanced phase chronic myeloid leukemia definitions on overall survival.

Eur J Haematol 2017 10 15;99(4):381-382. Epub 2017 Aug 15.

Department of Internal Medicine/Hematology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12928DOI Listing
October 2017

Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia.

J Clin Oncol 2017 Jan 7;35(2):175-184. Epub 2016 Nov 7.

Sieghart Sopper, Günther Gastl, Matthias Baldauf, Zlatko Trajanoski, and Dominik Wolf, Medical University Innsbruck; Sieghart Sopper and Dominik Wolf, Tyrolean Cancer Research Institute; Matthias Baldauf, Oncotyrol, Innsbruck; Peter Valent, Medical University of Vienna, Vienna, Austria; Satu Mustjoki and Kimmo Porkka, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; Deborah White and Timothy Hughes, South Australian Health and Medical Research Institute and University of Adelaide School of Medicine, Adelaide, South Australia, Australia; Andreas Burchert, Universitätsklinikum Gießen und Marburg and Philipps Universität Marburg, Marburg; Andreas Hochhaus, Thomas Ernst, and Thomas Schenk, Universitätsklinikum Jena, Jena; Dominik Wolf, University Hospital of Bonn, Bonn, Germany; Bjørn T. Gjertsen, University of Bergen, Bergen, Norway; Frank Giles, Northwestern University, Chicago, IL; and Jeroen J.W.M. Janssen and Gert J. Ossenkoppele, Vrije Universiteit Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.0893DOI Listing
January 2017

Allogeneic stem-cell transplantation for blastic plasmacytoid dendritic cell neoplasm.

J Clin Oncol 2012 Mar 13;30(8):e102-3. Epub 2012 Feb 13.

Isala Clinics, Zwolle, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.35.8143DOI Listing
March 2012

Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells.

Immunotherapy 2011 Apr;3(4):569-76

Department of Hematology, Cancer Center Amsterdam/VUmc Institute for Cancer & Immunology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/imt.11.3
Publisher Site
http://dx.doi.org/10.2217/imt.11.3DOI Listing
April 2011

A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment.

Am J Hematol 2009 Oct;84(10):679-82

Department of Hematology, VU University Medical Center, HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21489DOI Listing
October 2009

Towards cure of CML: why we need to know more about CML stem cells?

Curr Stem Cell Res Ther 2009 Sep;4(3):224-36

Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
September 2009

High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome.

Haematologica 2008 Dec;93(12):1894-8

Department of Hematology, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.13113DOI Listing
December 2008

A novel mutation in a Turkish patient with Hermansky-Pudlak syndrome type 5.

Eur J Haematol 2008 Apr 21;80(4):356-60. Epub 2007 Dec 21.

Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2007.01024.xDOI Listing
April 2008

Reduced supportive capacity of bone marrow stroma upon chemotherapy is mediated via changes in glycosaminoglycan profile.

Matrix Biol 2007 Sep 19;26(7):561-71. Epub 2007 Apr 19.

Department of Hematology, VU University Medical Center, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.matbio.2007.04.006DOI Listing
September 2007

Bone marrow stromal proteoglycans regulate megakaryocytic differentiation of human progenitor cells.

Exp Cell Res 2004 Oct;299(2):383-92

Department of Hematology, VU University Medical Center, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2004.06.018DOI Listing
October 2004